A new Zealand black-derived locus suppresses chronic graft-versus-host disease and autoantibody production through nonlymphoid bone marrow-derived cells

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 4130-4139

  Xu, Zhiwei ^a   Vallurupalli, Anusha ^a   Fuhrman, Christopher ^a   Ostrov, David ^a   Morel, Laurence ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD11B ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; BONE MARROW CELL; CELL ACTIVATION; CELL COUNT; CFS3R GENE; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC SUSCEPTIBILITY; GRANULOCYTE; HEMATOPOIETIC CELL; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SLE2C2 GENE; SUPPRESSOR CELL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; BONE MARROW CELLS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; GENES, SUPPRESSOR; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GRAFT VS HOST DISEASE; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED C57BL; MICE, INBRED NZB; MICE, KNOCKOUT; MYELOID CELLS; T-LYMPHOCYTES;

EID: 79955046029     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003512     Document Type: Article

References (36)

1. Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer, and E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1: 219-229.
2. Mohan, C., E. Alas, L. Morel, P. Yang, and E. K. Wakeland. 1998. Genetic dissection of SLE pathogenesis: Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J. Clin. Invest. 101: 1362-1372. (Pubitemid 28145253)
3. Morel, L., B. P. Croker, K. R. Blenman, C. Mohan, G. Huang, G. Gilkeson, and E. K. Wakeland. 2000. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. USA 97: 6670-6675. (Pubitemid 30412772)
4. Morel, L., X. H. Tian, B. P. Croker, and E. K. Wakeland. 1999. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 11: 131-139. (Pubitemid 29428806)
5. Subramanian, S., Y. S. Yim, K. Liu, K. Tus, X. J. Zhou, and E. K. Wakeland. 2005. Epistatic suppression of systemic lupus erythematosus: fine mapping of Sles1 to less than 1 mb. J. Immunol. 175: 1062-1072. (Pubitemid 41094992)
6. Haywood, M. E. K., L. Gabriel, S. J. Rose, N. J. Rogers, S. Izui, and B. J. Morley. 2007. BXSB/long-lived is a recombinant inbred strain containing powerful disease suppressor loci. J. Immunol. 179: 2428-2434.
7. Wang, Y., M. Nose, T. Kamoto, M. Nishimura, and H. Hiai. 1997. Host modifier genes affect mouse autoimmunity induced by the lpr gene. Am. J. Pathol. 151: 1791-1798. (Pubitemid 27527942)
8. Carlucci, F., L. Fossati-Jimack, I. E. Dumitriu, Y. Heidari, M. J. Walport, M. Szajna, P. Baruah, O. A. Garden, H. T. Cook, and M. Botto. 2010. Identification and characterization of a lupus suppressor 129 locus on chromosome 3. J. Immunol. 184: 6256-6265.doi:10.4049/jimmunol.0901463.
9. Haraldsson, M. K., C. A. Louis-Dit-Sully, B. R. Lawson, G. Sternik, M. L. Santiago-Raber, N. R. Gascoigne, A. N. Theofilopoulos, and D. H. Kono. 2008. The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation. Immunity 28: 40-51.
10. Mohan, C., L. Morel, P. Yang, and E. K. Wakeland. 1997. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J. Immunol. 159: 454-465. (Pubitemid 127493732)
11. Xu, Z., B. Duan, B. P. Croker, E. K. Wakeland, and L. Morel. 2005. Genetic dissection of the murine lupus susceptibility locus Sle2: Contributions to increased peritoneal B-1a cells and lupus nephritis map to different loci. J. Immunol. 175: 936-943. (Pubitemid 41094977)
12. Xu, Z., C. M. Cuda, B. P. Croker, and L. Morel. 2010. The NZM2410-derived lupus susceptibility locus Sle2c1 increases TH17 polarization and induces nephritis in Fas-deficient mice. Arthritis Rheum, DOI:10.1002/art.30146.
13. Eisenberg, R. 1998. Mechanisms of systemic autoimmunity in murine models of SLE. Immunol. Res. 17: 41-47. (Pubitemid 28072393)
14. Morris, S. C., R. L. Cheek, P. L. Cohen, and R. A. Eisenberg. 1990. Autoantibodies in chronic graft versus host result from cognate T-B interactions. J. Exp. Med. 171: 503-517. (Pubitemid 20059044)
15. Choudhury, A., P. L. Cohen, and R. A. Eisenberg. 2010. B cells require "nurturing" by CD4 T cells during development in order to respond in chronic graftversus-host model of systemic lupus erythematosus. Clin. Immunol. 136: 105-115.
16. Chen, Y., C. Cuda, and L. Morel. 2005. Genetic determination of T cell help in loss of tolerance to nuclear antigens. J. Immunol. 174: 7692-7702. (Pubitemid 40806274)
17. Cuda, C. M., L. Zeumer, E. S. Sobel, B. P. Croker, and L. Morel. 2010. Murine lupus susceptibility locus Sle1a requires the expression of two sub-loci to induce inflammatory T cells. Genes Immun. 11: 542-553.
18. Morris, E. S., K. P. A. MacDonald, R. D. Kuns, H. M. Morris, T. Banovic, A. L. J. Don, V. Rowe, Y. A. Wilson, N. C. Raffelt, C. R. Engwerda, et al. 2009. Induction of natural killer T cell-dependent alloreactivity by administration of granulocyte colony-stimulating factor after bone marrow transplantation. Nat. Med. 15: 436-441.
19. Highfill, S. L., P. C. Rodriguez, Q. Zhou, C. A. Goetz, B. H. Koehn, R. Veenstra, P. A. Taylor, A. Panoskaltsis-Mortari, J. S. Serody, D. H. Munn, et al. 2010. Bone marrow myeloid-derived suppressor cells (MDSC) inhibit graft-versus-host (GVHD) disease via an arginase-1 dependent mechanism that is upregulated by IL-13. Blood 116: 5738-5747.doi:10.1182/blood-2010-06-287839.
20. Ostrand-Rosenberg, S., and P. Sinha. 2009. Myeloid-derived suppressor cells: Linking inflammation and cancer. J. Immunol. 182: 4499-4506.
21. Cohen, J. L., A. Trenado, D. Vasey, D. Klatzmann, and B. L. Salomon. 2002. CD4(+)CD25(+) immunoregulatory T cells: New therapeutics for graft-versushost disease. J. Exp. Med. 196: 401-406. (Pubitemid 34875668)
22. Anderson, B. E., J. M. McNiff, C. Matte, I. Athanasiadis, W. D. Shlomchik, and M. J. Shlomchik. 2004. Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease. Blood 104: 1565-1573. (Pubitemid 39166539)
23. Puliaev, R., P. Nguyen, F. D. Finkelman, and C. S. Via. 2004. Differential requirement for IFN-gamma in CTL maturation in acute murine graft-versus-host disease. J. Immunol. 173: 910-919. (Pubitemid 38924264)
24. Vremec, D., M. O'Keeffe, H. Hochrein, M. Fuchsberger, I. Caminschi, M. Lahoud, and K. Shortman. 2007. Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells. Blood 109: 1165-1173. (Pubitemid 46220664)
25. Sobel, E. S., M. Satoh, Y. Chen, E. K. Wakeland, and L. Morel. 2002. The major murine systemic lupus erythematosus susceptibility locus Sle1 results in abnormal functions of both B and T cells. J. Immunol. 169: 2694-2700. (Pubitemid 34921018)
26. Tamada, T., E. Honjo, Y. Maeda, T. Okamoto, M. Ishibashi, M. Tokunaga, and R. Kuroki. 2006. Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex. Proc. Natl. Acad. Sci. USA 103: 3135-3140. (Pubitemid 43346437)
27. Marchler-Bauer, A., J. B. Anderson, F. Chitsaz, M. K. Derbyshire, C. DeWeese-Scott, J. H. Fong, L. Y. Geer, R. C. Geer, N. R. Gonzales, M. Gwadz, et al. 2009. CDD: specific functional annotation with the Conserved Domain Database. Nucleic Acids Res. 37(Database issue): D205-D210.
28. Fraser, J. S., Z. Yu, K. L. Maxwell, and A. R. Davidson. 2006. Ig-like domains on bacteriophages: A tale of promiscuity and deceit. J. Mol. Biol. 359: 496-507.
29. Kiefer, F., K. Arnold, M. Künzli, L. Bordoli, and T. Schwede. 2009. The SWISSMODEL Repository and associated resources. Nucleic Acids Res. 37(Database issue): D387-D392.
30. Ridgway, W. M., L. B. Peterson, J. A. Todd, D. B. Rainbow, B. Healy, O. S. Burren, and L. S. Wicker. 2008. Gene-gene interactions in the NOD mouse model of type 1 diabetes, Ch. 6. In Advances in Immunology Immunopathogenesis of Type 1 Diabetes Mellitus. R.U.a. H. Emil, ed. Academic Press, New York, NY, p. 151.
31. Dolcetti, L., E. Peranzoni, S. Ugel, I. Marigo, A. Fernandez Gomez, C. Mesa, M. Geilich, G. Winkels, E. Traggiai, A. Casati, et al. 2010. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 40: 22-35.
32. Iwata, Y., K. Furuichi, K. Kitagawa, A. Hara, T. Okumura, S. Kokubo, K. Shimizu, N. Sakai, A. Sagara, Y. Kurokawa, et al. 2010. Involvement of CD11b+ GR-1low cells in autoimmune disorder in MRL-Faslpr mouse. Clin. Exp. Nephrol. 14: 411-417.
33. Rutella, S., F. Zavala, S. Danese, H. Kared, and G. Leone. 2005. Granulocyte colony-stimulating factor: A novel mediator of T cell tolerance. J. Immunol. 175: 7085-7091. (Pubitemid 41713399)
34. Pan, L., J. J. Delmonte, Jr., C. K. Jalonen, and J. L. Ferrara. 1995. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 86: 4422-4429.
35. Zavala, F., A. Masson, K. Hadaya, S. Ezine, E. Schneider, O. Babin, and J. F. Bach. 1999. Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice. J. Immunol. 163: 5125-5132. (Pubitemid 29501282)
36. Morel, L. 2010. Genetics of SLE: Evidence from mouse models. Nat. Rev. Rheumatol. 6: 348-357.